A carregar...
Renal Failure among Multiple Myeloma patients utilizing Carfilzomib and Associated Factors in the ‘Real-World’
BACKGROUND: Carfilzomib, a next generation proteasome inhibitor, improves outcomes in patients with multiple myeloma (MM); however, a proportion of those treated develop renal failure due to adverse event, comorbidity, or myeloma progression. The rate of renal failure and associated risk factors rem...
Na minha lista:
| Publicado no: | Ann Hematol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054467/ https://ncbi.nlm.nih.gov/pubmed/33475778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-021-04420-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|